1-amino-1,3-dicarboxycyclopentane has been researched along with amphetamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kronthaler, UO; Schmidt, WJ | 1 |
| Kim, JH; Vezina, P | 1 |
| Kim, JH; Meeker, D; Vezina, P | 1 |
3 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and amphetamine
| Article | Year |
|---|---|
1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.
Topics: Amphetamine; Animals; Catalepsy; Cycloleucine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Locomotion; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reaction Time | 1996 |
The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats.
Topics: Amphetamine; Animals; Benzoates; Central Nervous System Stimulants; Cycloleucine; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Injections, Intraventricular; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate | 1998 |
Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation.
Topics: Amphetamine; Animals; Cycloleucine; Dopamine; Locomotion; Male; Microinjections; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate | 1998 |